BVF GP HOLDINGS LLC

See Explanation of Responses at CTI BIOPHARMA CORP · on record since Jun 28, 2023
10% owner at PALVELLA THERAPEUTICS, INC. · on record since May 22, 2023
Former 10% Owner at POINT Biopharma Global Inc. · on record since Dec 20, 2023
10% owner at enGene Therapeutics Inc. · on record since Nov 13, 2023
10% owner at POINT Biopharma Global Inc. · on record since Nov 6, 2023
See Remarks; Former 10% Owner at Rain Oncology Inc. · on record since Apr 27, 2021
10% owner at Allakos Inc. · on record since Jan 26, 2024
See Explanation of Responses at PALVELLA THERAPEUTICS, INC. · on record since Dec 17, 2024
See Explanation of Responses at 4D Molecular Therapeutics, Inc. · on record since Nov 13, 2024
See Explanation of Responses at Olema Pharmaceuticals, Inc. · on record since Dec 4, 2024
Director at IMMUNIC, INC. · on record since Feb 27, 2026
See Explanation of Responses at IMMUNIC, INC. · on record since Feb 27, 2026
Director at MoonLake Immunotherapeutics · on record since Apr 2, 2026
10% owner at MoonLake Immunotherapeutics · on record since Apr 2, 2026
10% owner at XOMA Royalty Corp · on record since May 18, 2026
10% owner at CTI BIOPHARMA CORP · on record since Mar 4, 2020
See Explanation of Responses at IDEAYA Biosciences, Inc. · on record since Jun 22, 2020
10% owner at FIVE PRIME THERAPEUTICS, INC. · on record since May 18, 2020
10% owner at · on record since Jun 10, 2020
10% owner at · on record since Aug 20, 2020
See Explanation of Responses at · on record since Dec 28, 2020
10% owner at · on record since Dec 28, 2020
10% owner at · on record since Nov 20, 2020
See Explanation of Responses at · on record since Nov 20, 2020
See Explanation of Responses at · on record since Nov 13, 2020
10% owner at · on record since Nov 6, 2020
10% owner at · on record since Oct 5, 2020
10% owner at · on record since Jan 26, 2021
See Explanation of Responses at · on record since Feb 19, 2021
See Explanation of Responses at · on record since Feb 18, 2021
10% owner at · on record since Sep 23, 2021
See Explanation of Responses at · on record since Oct 8, 2021
10% owner at · on record since Nov 8, 2021
10% owner at · on record since Jan 10, 2022
10% owner at · on record since Feb 7, 2022
10% owner at · on record since Jun 27, 2022
Director at · on record since May 20, 2022
Director at · on record since Jun 14, 2022
10% owner at · on record since Jul 21, 2022
Director at · on record since Aug 11, 2022
See Explanation of Responses at · on record since Dec 22, 2022
Director at · on record since Nov 10, 2022
Director at · on record since Jan 13, 2023
See Remarks and Footnotes at · on record since Aug 25, 2020
10% owner at · on record since Feb 13, 2023
10% owner at · on record since Oct 5, 2026

Insider trading activity of BVF GP HOLDINGS LLC

Transactions on record: 39; since Sep 17, 2020

Open-market buys: 30; $33.2M

Open-market sells: 2; $10.6M

Companies traded: 7; last filing Jun 17, 2025

Figures computed from official regulatory filings — .

Companies where BVF GP HOLDINGS LLC has traded

6 tx · Jun 17, 2025
8 tx · $11.1M · May 20, 2025
1 tx · Jun 12, 2023
3 tx · $3.6M · May 20, 2022
15 tx · $25.7M · Sep 23, 2021
3 tx · $1.7M · Oct 8, 2020
3 tx · $1.7M · Sep 17, 2020

Track record of BVF GP HOLDINGS LLC

Statistical track record

Free account

Open-market buys: 30

Last buy: Sep 27, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BVF GP HOLDINGS LLC

Co-insiders of BVF GP HOLDINGS LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	Other	556,617	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	OtherD (derivative)	304,098	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	OtherD (derivative)	25,944	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	Other	657,308	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	OtherD (derivative)	257,515	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	Other	56,079	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	May 20, 2025	Sell	-265,316	27.10 USD	$7.2M		SEC
XOMA Royalty CorpSecurity delisted	May 20, 2025	Sell	-127,407	27.10 USD	$3.5M		SEC
MoonLake ImmunotherapeuticsListing on record	Jun 12, 2023	AwardD (derivative)	11,297	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	6,715	16.50 USD	$110.8K	conv 26	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	3,339	16.83 USD	$56.2K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	1,004	16.89 USD	$17K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	9,885	16.50 USD	$163.1K	conv 26	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	3,021	16.83 USD	$50.8K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	678	16.89 USD	$11.5K	conv 21	SEC
Repare Therapeutics Inc.Listing unverified	May 20, 2022	Buy	224,388	8.50 USD	$1.9M	conv 20	SEC
Repare Therapeutics Inc.Listing unverified	May 20, 2022	Buy	5,730	8.50 USD	$48.7K	conv 15	SEC
Repare Therapeutics Inc.Listing unverified	May 20, 2022	Buy	189,882	8.50 USD	$1.6M	conv 19	SEC
Rain Oncology Inc.Listing unverified	Sep 23, 2021	Buy	590	13.94 USD	$8.2K	conv 29Cluster	SEC
Rain Oncology Inc.Listing unverified	Sep 23, 2021	Buy	4,102	13.94 USD	$57.2K	conv 29Cluster	SEC
Rain Oncology Inc.Listing unverified	Sep 23, 2021	Buy	6,341	13.94 USD	$88.4K	conv 29Cluster	SEC
Rain Oncology Inc.Listing unverified	Sep 15, 2021	Buy	213,246	16.49 USD	$3.5M	conv 32	SEC
Rain Oncology Inc.Listing unverified	Sep 15, 2021	Buy	20,512	16.49 USD	$338.2K	conv 23	SEC
Rain Oncology Inc.Listing unverified	Sep 15, 2021	Buy	158,511	16.49 USD	$2.6M	conv 29	SEC
Rain Oncology Inc.Listing unverified	May 17, 2021	Buy	398,300	17.00 USD	$6.8M	conv 84ClusterUnusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	Other	556,617	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	OtherD (derivative)	304,098	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	OtherD (derivative)	25,944	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	Other	657,308	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	OtherD (derivative)	257,515	—	n/a (No price was disclosed in the filing)		SEC
CRESCENT BIOPHARMA, INC.Listing unverified	Jun 17, 2025	Other	56,079	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	May 20, 2025	Sell	-265,316	27.10 USD	$7.2M		SEC
XOMA Royalty CorpSecurity delisted	May 20, 2025	Sell	-127,407	27.10 USD	$3.5M		SEC
MoonLake ImmunotherapeuticsListing on record	Jun 12, 2023	AwardD (derivative)	11,297	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	6,715	16.50 USD	$110.8K	conv 26	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	3,339	16.83 USD	$56.2K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	1,004	16.89 USD	$17K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	9,885	16.50 USD	$163.1K	conv 26	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	3,021	16.83 USD	$50.8K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 27, 2022	Buy	678	16.89 USD	$11.5K	conv 21	SEC
Repare Therapeutics Inc.Listing unverified	May 20, 2022	Buy	224,388	8.50 USD	$1.9M	conv 20	SEC
Repare Therapeutics Inc.Listing unverified	May 20, 2022	Buy	5,730	8.50 USD	$48.7K	conv 15	SEC
Repare Therapeutics Inc.Listing unverified	May 20, 2022	Buy	189,882	8.50 USD	$1.6M	conv 19	SEC
Rain Oncology Inc.Listing unverified	Sep 23, 2021	Buy	590	13.94 USD	$8.2K	conv 29Cluster	SEC
Rain Oncology Inc.Listing unverified	Sep 23, 2021	Buy	4,102	13.94 USD	$57.2K	conv 29Cluster	SEC
Rain Oncology Inc.Listing unverified	Sep 23, 2021	Buy	6,341	13.94 USD	$88.4K	conv 29Cluster	SEC
Rain Oncology Inc.Listing unverified	Sep 15, 2021	Buy	213,246	16.49 USD	$3.5M	conv 32	SEC
Rain Oncology Inc.Listing unverified	Sep 15, 2021	Buy	20,512	16.49 USD	$338.2K	conv 23	SEC
Rain Oncology Inc.Listing unverified	Sep 15, 2021	Buy	158,511	16.49 USD	$2.6M	conv 29	SEC
Rain Oncology Inc.Listing unverified	May 17, 2021	Buy	398,300	17.00 USD	$6.8M	conv 84ClusterUnusual size	SEC